Citation Impact
Citing Papers
Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association
2016
Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia
2009
Molluscan Shell Proteins: Primary Structure, Origin, and Evolution
2007 Standout
Benchmarking the stability of human detergent-solubilised voltage-gated sodium channels for structural studies using eel as a reference
2015 StandoutNobel
Quantitating the epigenetic transformation contributing to cholesterol homeostasis using Gaussian process
2019
Structure of a mammalian ryanodine receptor
2014 StandoutNatureNobel
STRING v9.1: protein-protein interaction networks, with increased coverage and integration
2012 Standout
Structural Basis for Gating and Activation of RyR1
2016 StandoutNobel
Birth Prevalence of Congenital Heart Disease Worldwide
2011 Standout
Ryanodine receptors and ventricular arrhythmias: Emerging trends in mutations, mechanisms and therapies
2006
Sudden death in patients without structural heart disease
2004
The Cardiac Sodium Channel: Gating Function and Molecular Pharmacology
2001
The Brugada Syndrome: Is an Implantable Cardioverter Defibrillator the Only Therapeutic Option?
2002
Skeletal Muscle Fatigue: Cellular Mechanisms
2008 Standout
Under-recognition of 22q11.2 deletion in adult Chinese patients with conotruncal anomalies: Implications in transitional care
2014
Voltage-Gated Sodium Channels: Mutations, Channelopathies and Targets
2011
The FGF family: biology, pathophysiology and therapy
2009 Standout
Ryanodine Receptors: Allosteric Ion Channel Giants
2014
Calsequestrin and the calcium release channel of skeletal and cardiac muscle
2003
Safety and Efficacy of Flecainide in Subjects with Long QT‐3 Syndrome (ΔKPQ Mutation): A Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial
2005
Regulation of Co-transcriptional Pre-mRNA Splicing by m6A through the Low-Complexity Protein hnRNPG
2019
Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca2+ release channel
2007 StandoutNobel
Genome-wide Orchestration of Cardiac Functions by the Orphan Nuclear Receptors ERRα and γ
2007
Sudden cardiac death with normal heart:
2010
Structure of frozen–hydrated triad junctions: A case study in motif searching inside tomograms
2008 StandoutNobel
Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans
2009
A cardiac sodium channel mutation identified in Brugada syndrome associated with atrial standstill
2003
Hallmarks of aging: An expanding universe
2023 Standout
Exercise Standards for Testing and Training
2013 Standout
AI in health and medicine
2022 Standout
Hydroquinidine therapy in Brugada syndrome
2004
Genetic control of sodium channel function
2003
Ventricular Arrhythmias in the Absence of Structural Heart Disease
2012
The genetic basis of long QT and short QT syndromes: A mutation update
2009
22q11.21 Deletion Syndromes: A Review of Proximal, Central, and Distal Deletions and Their Associated Features
2015 Standout
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Modeling the human Na<sub>v</sub>1.5 sodium channel: structural and mechanistic insights of ion permeation and drug blockade
2017 StandoutNobel
Mouse models of SCN5A-related cardiac arrhythmias
2008
Secondary Structure of the Human Cardiac Na+ Channel C Terminus
2002
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Endurance exercise performance: the physiology of champions
2007 Standout
Sarcoplasmic reticulum: The dynamic calcium governor of muscle
2006
Fibroblast growth factor homologous factors: Evolution, structure, and function
2005
Computational tools for prioritizing candidate genes: boosting disease gene discovery
2012
Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia
2006
Verticilide, a new ryanodine-binding inhibitor, produced by Verticillium sp. FKI-1033
2010 StandoutNobel
New electrocardiographic leads and the procainamide test for the detection of the Brugada sign in sudden unexplained death syndrome survivors and their relatives
2001
The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule
2010 Nature
Left ventricular outflow tract obstruction: should cardiac screening be offered to first-degree relatives?
2011
Inherited disorders of voltage-gated sodium channels
2005
European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support
2010 Standout
The Human Gene Map for Performance and Health-Related Fitness Phenotypes
2006
Proposed Diagnostic Criteria for the Brugada Syndrome
2002
Molecular basis of ranolazine block of LQT‐3 mutant sodium channels: evidence for site of action
2006
The changing epidemiology of congenital heart disease
2010
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
2020 Standout
Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome
2002
Effect of Sodium Channel Blockers on ST Segment, QRS Duration, and Corrected QT Interval in Patients with Brugada Syndrome
2000
Catecholaminergic Polymorphic Ventricular Tachycardia
2008
Amplification of spatial dispersion of repolarization underlies sudden cardiac death associated with catecholaminergic polymorphic VT, long QT, short QT and Brugada syndromes
2005
ACTN3 Genotype Is Associated with Human Elite Athletic Performance
2003 Standout
The long QT syndromes: genetic basis and clinical implications
2000
Several common variants modulate heart rate, PR interval and QRS duration
2010
Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels
2006
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects
2013
Down syndrome
2020 Standout
22q11.2 deletion syndrome
2015 Standout
Congenital heart defects in a novel recurrent 22q11.2 deletion harboring the genes CRKL and MAPK1
2012
A model for human ventricular tissue
2004 Standout
Genetic causes of human heart failure
2005
Pharmacogenetics of antiarrhythmic therapy
2006
The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases
2014
Therapy for the Brugada Syndrome
2006
Novel Brugada SCN5A Mutation Leading to ST Segment Elevation in the Inferior or the Right Precordial Leads
2003
The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells
2009 StandoutNobel
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Compound Heterozygosity for Mutations (W156X and R225W) in SCN5A Associated With Severe Cardiac Conduction Disturbances and Degenerative Changes in the Conduction System
2003
The Fibroblast Growth Factor signaling pathway
2015 Standout
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2018
Familial Evaluation in Catecholaminergic Polymorphic Ventricular Tachycardia
2012
Modulation of the Ryanodine Receptor and Intracellular Calcium
2007
Proposed Diagnostic Criteria for the Brugada Syndrome
2002
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Cardiovascular effects of Danshen
2007 Standout
Abnormal Calcium Signaling and Sudden Cardiac Death Associated With Mutation of Calsequestrin
2004
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy
2020 Standout
Advances in the Understanding of the Genetic Determinants of Congenital Heart Disease and Their Impact on Clinical Outcomes
2018
Brugada Syndrome: Report of the Second Consensus Conference
2005 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Recent Stem Cell Advances: Induced Pluripotent Stem Cells for Disease Modeling and Stem Cell–Based Regeneration
2010 StandoutNobel
Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture
2011 StandoutNobel
Fiber Types in Mammalian Skeletal Muscles
2011 Standout
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
Multiplexed quantitative real-time PCR to detect 22q11.2 deletion in patients with congenital heart disease
2010
SIRT6, a Mammalian Deacylase with Multitasking Abilities
2019
Spectrum of Mutations in Long-QT Syndrome Genes
2000
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Gating-Dependent Mechanisms for Flecainide Action inSCN5A-Linked Arrhythmia Syndromes
2001
Sudden Unexplained Death
2005
Accelerated inactivation in a mutant Na+channel associated with idiopathic ventricular fibrillation
2001
Andersen–Tawil syndrome: Clinical and molecular aspects
2013
Lethal mitochondrial cardiomyopathy in a hypomorphic Med30 mouse mutant is ameliorated by ketogenic diet
2011 StandoutNobel
Molecular Basis of Arrhythmias
2005
Enhanced Na + Channel Intermediate Inactivation in Brugada Syndrome
2000
Cardiac Ion Channels
2002
Part 14: Pediatric Advanced Life Support
2010 Standout
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram
2009 Standout
Hypermorphic mutation of the voltage-gated sodium channel encoding gene Scn10a causes a dramatic stimulus-dependent neurobehavioral phenotype
2011 StandoutNobel
Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: Mechanism for hereditary arrhythmia
2003
Works of Alex V. Postma being referenced
An inactivating mutation in the histone deacetylase SIRT6 causes human perinatal lethality
2018
A Novel Early Onset Lethal Form of Catecholaminergic Polymorphic Ventricular Tachycardia Maps to Chromosome 7p14‐p22
2007
Haploinsufficiency of TAB2 Causes Congenital Heart Defects in Humans
2010
22q11.2 Deletion Syndrome is under-recognised in adult patients with tetralogy of Fallot and pulmonary atresia: Table 1
2010
Mutations in the Sarcomere Gene MYH7 in Ebstein Anomaly
2010
A Gain-of-Function TBX5 Mutation Is Associated With Atypical Holt–Oram Syndrome and Paroxysmal Atrial Fibrillation
2008
Expanding Spectrum of Human RYR2 -Related Disease
2007
Absence of Calsequestrin 2 Causes Severe Forms of Catecholaminergic Polymorphic Ventricular Tachycardia
2002
A Single Na + Channel Mutation Causing Both Long-QT and Brugada Syndromes
1999